Contact
Please use this form to send email to PR contact of this press release:
Cybrexa Therapeutics Reports Positive Results from GLP Toxicology Study of Lead Candidate CBX-12 (alphalex™-exatecan)
TO:
Please use this form to send email to PR contact of this press release:
Cybrexa Therapeutics Reports Positive Results from GLP Toxicology Study of Lead Candidate CBX-12 (alphalex™-exatecan)
TO: